Ventyx Biosciences, Inc.

Historical 13F Holders

Symbol
VTYX
CUSIP
92332V107
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 92332V107 since 12/18/2024, largest first.

Filer % of Class Filed
NSV Investments I, L.P. 13D/A
7.6% 3/12/2025
Event 3/10/2025
Raju Mohan 13D/A 6.0% 1/9/2026
Event 1/7/2026
NSV Partners III LP 13D/A
5.7% 4/1/2025
Event 3/28/2025
Vanguard Group Inc 13G 5.3% 10/31/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (11)
Point72 Asset Management, L.P. 13G/A
4.5% 11/14/2025
Event 9/30/2025
Sio Capital Management, LLC 13G/A 3.6% 4/8/2025
Event 3/31/2025
Citadel Advisors LLC 13G/A
2.0% 5/15/2025
Event 3/31/2025
BlackRock, Inc. 13G/A 1.9% 7/16/2025
Event 6/30/2025
Bank of America Corp /DE/ 13G/A 1.4% 5/15/2025
Event 3/31/2025
James E. Flynn 13G/A
0.8% 2/13/2025
Event 12/31/2024
Morgan Stanley 13G/A 0.3% 2/6/2026
Event 1/31/2026
Affinity Asset Advisors, LLC 13G/A
0% 5/14/2026
Event 3/31/2026
Glazer Capital, LLC 13G/A
0% 5/14/2026
Event 3/31/2026
Subramaniam Somu 13D/A 0% 3/5/2026
Event 3/4/2026
Tang Capital Management LLC 13G/A
0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 1 1.50 k $21.0 k
2025 Q4 153 52.2 M $472 M
2025 Q3 116 44.6 M $139 M
2025 Q2 120 44.5 M $95.2 M
2025 Q1 122 44.4 M $51.1 M
2024 Q4 131 54.5 M $119 M
2024 Q3 125 53.5 M $117 M
2024 Q2 127 58.9 M $136 M
2024 Q1 136 62.7 M $344 M
2023 Q4 133 46.7 M $115 M
2023 Q3 160 56.6 M $1.97 B
2023 Q2 165 55.0 M $1.80 B
2023 Q1 161 51.2 M $1.71 B
2022 Q4 136 45.0 M $1.47 B
2022 Q3 113 40.6 M $1.42 B
2022 Q2 64 34.6 M $424 M
2022 Q1 56 33.2 M $448 M
2021 Q4 47 31.6 M $619 M